

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | humoral immune response (GO:0006959) | 9.18255613 |
| 2 | keratinization (GO:0031424) | 8.10219381 |
| 3 | negative regulation of mast cell activation (GO:0033004) | 6.44966491 |
| 4 | positive regulation of respiratory burst (GO:0060267) | 6.44752330 |
| 5 | signal peptide processing (GO:0006465) | 6.09050109 |
| 6 | negative regulation of glucose import (GO:0046325) | 5.96729855 |
| 7 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 5.94246786 |
| 8 | cytidine deamination (GO:0009972) | 5.79521353 |
| 9 | cytidine metabolic process (GO:0046087) | 5.79521353 |
| 10 | cytidine catabolic process (GO:0006216) | 5.79521353 |
| 11 | B cell receptor signaling pathway (GO:0050853) | 5.00326618 |
| 12 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 4.97593449 |
| 13 | detection of bacterium (GO:0016045) | 4.97575367 |
| 14 | lung lobe morphogenesis (GO:0060463) | 4.94782784 |
| 15 | Fc-epsilon receptor signaling pathway (GO:0038095) | 4.84728017 |
| 16 | detection of other organism (GO:0098543) | 4.81934571 |
| 17 | phenylpropanoid metabolic process (GO:0009698) | 4.80024813 |
| 18 | negative regulation of glucose transport (GO:0010829) | 4.78014027 |
| 19 | Fc receptor signaling pathway (GO:0038093) | 4.74076250 |
| 20 | glomerular filtration (GO:0003094) | 4.70001255 |
| 21 | DNA deamination (GO:0045006) | 4.64309957 |
| 22 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 4.58279433 |
| 23 | polarized epithelial cell differentiation (GO:0030859) | 4.56148098 |
| 24 | establishment of skin barrier (GO:0061436) | 4.54471276 |
| 25 | respiratory tube development (GO:0030323) | 4.50558893 |
| 26 | negative regulation of B cell proliferation (GO:0030889) | 4.37795275 |
| 27 | immunoglobulin mediated immune response (GO:0016064) | 4.33124090 |
| 28 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.25321939 |
| 29 | lung vasculature development (GO:0060426) | 4.20998715 |
| 30 | immune response-regulating cell surface receptor signaling pathway (GO:0002768) | 4.20047935 |
| 31 | regulation of respiratory burst (GO:0060263) | 4.16283636 |
| 32 | positive regulation of macrophage cytokine production (GO:0060907) | 4.15433321 |
| 33 | renal filtration (GO:0097205) | 4.12424681 |
| 34 | cellular response to zinc ion (GO:0071294) | 4.02296067 |
| 35 | antimicrobial humoral response (GO:0019730) | 4.01959936 |
| 36 | proline biosynthetic process (GO:0006561) | 3.97417113 |
| 37 | midgut development (GO:0007494) | 3.87874350 |
| 38 | B cell mediated immunity (GO:0019724) | 3.87536346 |
| 39 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.80408730 |
| 40 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.79767486 |
| 41 | antibacterial humoral response (GO:0019731) | 3.75515550 |
| 42 | regulation of B cell proliferation (GO:0030888) | 3.73890913 |
| 43 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.73502132 |
| 44 | negative regulation of viral release from host cell (GO:1902187) | 3.73397090 |
| 45 | regulation of water loss via skin (GO:0033561) | 3.73387720 |
| 46 | T cell migration (GO:0072678) | 3.70843762 |
| 47 | immune response-activating signal transduction (GO:0002757) | 3.66438962 |
| 48 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.64296870 |
| 49 | detection of external biotic stimulus (GO:0098581) | 3.62507131 |
| 50 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.44069672 |
| 51 | lipoxygenase pathway (GO:0019372) | 3.42143590 |
| 52 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.38059492 |
| 53 | regulation of mast cell degranulation (GO:0043304) | 3.37656429 |
| 54 | activation of immune response (GO:0002253) | 3.32967334 |
| 55 | negative thymic T cell selection (GO:0045060) | 3.22283877 |
| 56 | regulation of viral release from host cell (GO:1902186) | 3.19645140 |
| 57 | positive regulation of antigen processing and presentation (GO:0002579) | 3.18645553 |
| 58 | establishment of apical/basal cell polarity (GO:0035089) | 3.17923451 |
| 59 | regulation of antigen processing and presentation (GO:0002577) | 3.17146461 |
| 60 | B cell proliferation (GO:0042100) | 3.16895725 |
| 61 | positive regulation of B cell differentiation (GO:0045579) | 3.16331964 |
| 62 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.16247618 |
| 63 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.15766890 |
| 64 | L-fucose catabolic process (GO:0042355) | 3.12544025 |
| 65 | fucose catabolic process (GO:0019317) | 3.12544025 |
| 66 | L-fucose metabolic process (GO:0042354) | 3.12544025 |
| 67 | detection of biotic stimulus (GO:0009595) | 3.10403580 |
| 68 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.08239394 |
| 69 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.08050697 |
| 70 | endocardial cushion development (GO:0003197) | 3.07588927 |
| 71 | regulation of natural killer cell differentiation (GO:0032823) | 3.06653196 |
| 72 | establishment of epithelial cell polarity (GO:0090162) | 3.05344139 |
| 73 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.04385700 |
| 74 | keratinocyte differentiation (GO:0030216) | 3.03880316 |
| 75 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.03051803 |
| 76 | peptide cross-linking (GO:0018149) | 3.02454101 |
| 77 | positive regulation of immunoglobulin production (GO:0002639) | 3.02263274 |
| 78 | complement activation, classical pathway (GO:0006958) | 27.3173007 |
| 79 | complement activation (GO:0006956) | 20.9670027 |
| 80 | regulation of B cell differentiation (GO:0045577) | 2.98784730 |
| 81 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.97029524 |
| 82 | positive regulation of T cell chemotaxis (GO:0010820) | 2.96639779 |
| 83 | regulation of T cell chemotaxis (GO:0010819) | 2.96639779 |
| 84 | cardiac left ventricle morphogenesis (GO:0003214) | 2.93306631 |
| 85 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.91810736 |
| 86 | negative T cell selection (GO:0043383) | 2.89222056 |
| 87 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.88576013 |
| 88 | lymphocyte migration (GO:0072676) | 2.87121205 |
| 89 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.86665262 |
| 90 | positive regulation of protein homooligomerization (GO:0032464) | 2.86442439 |
| 91 | negative regulation of interleukin-12 production (GO:0032695) | 2.84616119 |
| 92 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.82975660 |
| 93 | macrophage activation involved in immune response (GO:0002281) | 2.81765386 |
| 94 | regulation of mast cell activation (GO:0033003) | 2.81180868 |
| 95 | NIK/NF-kappaB signaling (GO:0038061) | 2.80399530 |
| 96 | polyketide metabolic process (GO:0030638) | 2.78913851 |
| 97 | doxorubicin metabolic process (GO:0044598) | 2.78913851 |
| 98 | daunorubicin metabolic process (GO:0044597) | 2.78913851 |
| 99 | positive regulation by symbiont of host defense response (GO:0052509) | 2.78070772 |
| 100 | modulation by symbiont of host defense response (GO:0052031) | 2.78070772 |
| 101 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.78070772 |
| 102 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.78070772 |
| 103 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.78070772 |
| 104 | modulation by symbiont of host immune response (GO:0052553) | 2.78070772 |
| 105 | mast cell activation (GO:0045576) | 2.75435180 |
| 106 | nucleoside diphosphate catabolic process (GO:0009134) | 2.74345317 |
| 107 | regulation of macrophage cytokine production (GO:0010935) | 2.73809973 |
| 108 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.73595916 |
| 109 | regulation of hypersensitivity (GO:0002883) | 2.71311501 |
| 110 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.70975194 |
| 111 | xenobiotic catabolic process (GO:0042178) | 2.69091055 |
| 112 | proline metabolic process (GO:0006560) | 2.69059128 |
| 113 | regulation of B cell apoptotic process (GO:0002902) | 2.68943193 |
| 114 | response to interleukin-15 (GO:0070672) | 2.68186625 |
| 115 | type I interferon signaling pathway (GO:0060337) | 2.67802883 |
| 116 | cellular response to type I interferon (GO:0071357) | 2.67802883 |
| 117 | respiratory burst (GO:0045730) | 2.67637392 |
| 118 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.67285345 |
| 119 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.67139187 |
| 120 | cellular response to interferon-gamma (GO:0071346) | 2.64290502 |
| 121 | regulation of germinal center formation (GO:0002634) | 2.63995515 |
| 122 | tissue homeostasis (GO:0001894) | 2.61552068 |
| 123 | aldehyde catabolic process (GO:0046185) | 2.58648169 |
| 124 | negative regulation of B cell activation (GO:0050869) | 2.56078113 |
| 125 | cofactor catabolic process (GO:0051187) | 2.55882097 |
| 126 | regulation of B cell activation (GO:0050864) | 2.53346227 |
| 127 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.47999100 |
| 128 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.47999100 |
| 129 | COPI coating of Golgi vesicle (GO:0048205) | 2.45948310 |
| 130 | Golgi transport vesicle coating (GO:0048200) | 2.45948310 |
| 131 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.42845497 |
| 132 | negative regulation of cellular response to insulin stimulus (GO:1900077) | 2.34954483 |
| 133 | thymic T cell selection (GO:0045061) | 2.32877250 |
| 134 | benzene-containing compound metabolic process (GO:0042537) | 2.31659394 |
| 135 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.24074614 |
| 136 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.18519136 |
| 137 | positive regulation of production of molecular mediator of immune response (GO:0002702) | 2.16890943 |
| 138 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.16646506 |
| 139 | L-phenylalanine catabolic process (GO:0006559) | 2.16646506 |
| 140 | regulation of immunoglobulin production (GO:0002637) | 2.16267970 |
| 141 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.16090649 |
| 142 | protein maturation by protein folding (GO:0022417) | 2.13355374 |
| 143 | negative regulation of B cell apoptotic process (GO:0002903) | 2.12907859 |
| 144 | peptidyl-asparagine modification (GO:0018196) | 2.11489846 |
| 145 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.10805348 |
| 146 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.10805348 |
| 147 | positive thymic T cell selection (GO:0045059) | 2.08871070 |
| 148 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.08012434 |
| 149 | primary alcohol catabolic process (GO:0034310) | 2.07640615 |
| 150 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.07596000 |
| 151 | aromatic amino acid family catabolic process (GO:0009074) | 2.06679174 |
| 152 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.02792157 |
| 153 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.02580210 |
| 154 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.02379306 |
| 155 | I-kappaB phosphorylation (GO:0007252) | 2.01691881 |
| 156 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.00280134 |
| 157 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.00203900 |
| 158 | protein activation cascade (GO:0072376) | 13.6880519 |
| 159 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 11.2453600 |
| 160 | Fc-gamma receptor signaling pathway (GO:0038094) | 11.2453600 |
| 161 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 11.2453600 |
| 162 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 11.1142244 |
| 163 | retina homeostasis (GO:0001895) | 10.2530767 |
| 164 | detection of molecule of bacterial origin (GO:0032490) | 1.98818137 |
| 165 | protein N-linked glycosylation (GO:0006487) | 1.96897119 |
| 166 | regulation of cytokine secretion involved in immune response (GO:0002739) | 1.96659773 |
| 167 | T cell selection (GO:0045058) | 1.94053796 |
| 168 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 1.93386530 |
| 169 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 1.92410428 |
| 170 | positive regulation of B cell proliferation (GO:0030890) | 1.92274768 |
| 171 | mast cell activation involved in immune response (GO:0002279) | 1.91599370 |
| 172 | mast cell degranulation (GO:0043303) | 1.91599370 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.66371479 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.86712241 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.82627975 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.51510002 |
| 5 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 4.51374409 |
| 6 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 4.45066184 |
| 7 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.43259939 |
| 8 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.97194549 |
| 9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.85651820 |
| 10 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.68068742 |
| 11 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 3.22200468 |
| 12 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.17969944 |
| 13 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.15278664 |
| 14 | MYC_22102868_ChIP-Seq_BL_Human | 3.11389915 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.85796039 |
| 16 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.70904099 |
| 17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.61405994 |
| 18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.57950371 |
| 19 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.55324533 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.53820698 |
| 21 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.53646797 |
| 22 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.47368817 |
| 23 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.44518529 |
| 24 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.41525274 |
| 25 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.17723404 |
| 26 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.16678815 |
| 27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.11476718 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 2.07124681 |
| 29 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.06988206 |
| 30 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.06784952 |
| 31 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.03481782 |
| 32 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.00687065 |
| 33 | MAF_26560356_Chip-Seq_TH1_Human | 2.00494729 |
| 34 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.94411731 |
| 35 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.92691479 |
| 36 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.85009010 |
| 37 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.77441242 |
| 38 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.75266424 |
| 39 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.71357825 |
| 40 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.69268493 |
| 41 | MYB_26560356_Chip-Seq_TH2_Human | 1.69040726 |
| 42 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.67595976 |
| 43 | GATA3_26560356_Chip-Seq_TH2_Human | 1.65613878 |
| 44 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.64911197 |
| 45 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64000780 |
| 46 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.61519071 |
| 47 | MYB_26560356_Chip-Seq_TH1_Human | 1.57672331 |
| 48 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.51946548 |
| 49 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.50562510 |
| 50 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.47503640 |
| 51 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.47233322 |
| 52 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.46769441 |
| 53 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.46384310 |
| 54 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.45083686 |
| 55 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.44275344 |
| 56 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.37737835 |
| 57 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.37266791 |
| 58 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.34231167 |
| 59 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.33736846 |
| 60 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.30120917 |
| 61 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.28055000 |
| 62 | UTX_26944678_Chip-Seq_JUKART_Human | 1.26202960 |
| 63 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.25880606 |
| 64 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.25480348 |
| 65 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.24681516 |
| 66 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.23720810 |
| 67 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.23175053 |
| 68 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22380107 |
| 69 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.21973518 |
| 70 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.21431415 |
| 71 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.21429754 |
| 72 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.19824777 |
| 73 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.19137283 |
| 74 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.19007595 |
| 75 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.17833764 |
| 76 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.16686853 |
| 77 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.16532520 |
| 78 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.14799704 |
| 79 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.14780929 |
| 80 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.14474242 |
| 81 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.14342812 |
| 82 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.12150172 |
| 83 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.11106179 |
| 84 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.10542559 |
| 85 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.09630348 |
| 86 | GATA1_19941826_ChIP-Seq_K562_Human | 1.09324304 |
| 87 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.08298135 |
| 88 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.07784396 |
| 89 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.07594059 |
| 90 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.04109462 |
| 91 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.04068674 |
| 92 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.03646966 |
| 93 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.02223279 |
| 94 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02005744 |
| 95 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00517114 |
| 96 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99550630 |
| 97 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.99389459 |
| 98 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.98858183 |
| 99 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.98858183 |
| 100 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98604556 |
| 101 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.98125185 |
| 102 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.98038869 |
| 103 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.97859373 |
| 104 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97478278 |
| 105 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97242804 |
| 106 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96265207 |
| 107 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.96215605 |
| 108 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95036285 |
| 109 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.95024769 |
| 110 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.94663278 |
| 111 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.93539938 |
| 112 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93428762 |
| 113 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.93097175 |
| 114 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.92753590 |
| 115 | SPI1_23127762_ChIP-Seq_K562_Human | 0.91215819 |
| 116 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91082762 |
| 117 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.90313128 |
| 118 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.89931923 |
| 119 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.89691306 |
| 120 | GATA2_19941826_ChIP-Seq_K562_Human | 0.89594092 |
| 121 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.88937777 |
| 122 | MAF_26560356_Chip-Seq_TH2_Human | 0.88783149 |
| 123 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.88688832 |
| 124 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.87123251 |
| 125 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86679474 |
| 126 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.85710531 |
| 127 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.85707104 |
| 128 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.85646960 |
| 129 | P300_27268052_Chip-Seq_Bcells_Human | 0.85252196 |
| 130 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.85035037 |
| 131 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.84799631 |
| 132 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.84610538 |
| 133 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.84091533 |
| 134 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.83532377 |
| 135 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.83440755 |
| 136 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.83184281 |
| 137 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.82850528 |
| 138 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.82271410 |
| 139 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.81948822 |
| 140 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.81940499 |
| 141 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.81437421 |
| 142 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.81345310 |
| 143 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80610368 |
| 144 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.79925799 |
| 145 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79010688 |
| 146 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.78682722 |
| 147 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.78596934 |
| 148 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.78545912 |
| 149 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.78397577 |
| 150 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.77054017 |
| 151 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.75939636 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.64011962 |
| 2 | MP0001800_abnormal_humoral_immune | 4.47470329 |
| 3 | MP0002796_impaired_skin_barrier | 3.81676459 |
| 4 | MP0005671_abnormal_response_to | 3.81365067 |
| 5 | MP0002138_abnormal_hepatobiliary_system | 3.78992878 |
| 6 | MP0003724_increased_susceptibility_to | 3.77387966 |
| 7 | MP0003303_peritoneal_inflammation | 3.33455531 |
| 8 | MP0001790_abnormal_immune_system | 3.29126642 |
| 9 | MP0005387_immune_system_phenotype | 3.29126642 |
| 10 | MP0002452_abnormal_antigen_presenting | 3.11893328 |
| 11 | MP0002876_abnormal_thyroid_physiology | 3.02500302 |
| 12 | MP0000685_abnormal_immune_system | 2.83706629 |
| 13 | MP0002723_abnormal_immune_serum | 2.73328024 |
| 14 | MP0005275_abnormal_skin_tensile | 2.68533018 |
| 15 | MP0006054_spinal_hemorrhage | 2.68476132 |
| 16 | MP0002148_abnormal_hypersensitivity_rea | 2.51552586 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.50885218 |
| 18 | MP0001819_abnormal_immune_cell | 2.45533727 |
| 19 | MP0005000_abnormal_immune_tolerance | 2.38765809 |
| 20 | MP0002139_abnormal_hepatobiliary_system | 2.37217651 |
| 21 | MP0002398_abnormal_bone_marrow | 2.27334528 |
| 22 | MP0000716_abnormal_immune_system | 2.24646225 |
| 23 | MP0002166_altered_tumor_susceptibility | 2.13525620 |
| 24 | MP0005501_abnormal_skin_physiology | 2.07470766 |
| 25 | MP0005360_urolithiasis | 1.94954004 |
| 26 | MP0010234_abnormal_vibrissa_follicle | 1.89593209 |
| 27 | MP0000689_abnormal_spleen_morphology | 1.87125662 |
| 28 | MP0005025_abnormal_response_to | 1.86911247 |
| 29 | MP0002429_abnormal_blood_cell | 1.80351978 |
| 30 | MP0002163_abnormal_gland_morphology | 1.77296646 |
| 31 | MP0002419_abnormal_innate_immunity | 1.76931204 |
| 32 | MP0005085_abnormal_gallbladder_physiolo | 1.70469074 |
| 33 | MP0002006_tumorigenesis | 1.65158280 |
| 34 | MP0004947_skin_inflammation | 1.64031022 |
| 35 | MP0004859_abnormal_synaptic_plasticity | 1.58596760 |
| 36 | MP0005310_abnormal_salivary_gland | 1.56956984 |
| 37 | MP0000579_abnormal_nail_morphology | 1.54379699 |
| 38 | MP0002722_abnormal_immune_system | 1.53909373 |
| 39 | MP0000920_abnormal_myelination | 1.52642711 |
| 40 | MP0001845_abnormal_inflammatory_respons | 1.52008375 |
| 41 | MP0003941_abnormal_skin_development | 1.50413001 |
| 42 | MP0006082_CNS_inflammation | 1.47486608 |
| 43 | MP0010094_abnormal_chromosome_stability | 1.45161763 |
| 44 | MP0004782_abnormal_surfactant_physiolog | 1.43600319 |
| 45 | MP0004145_abnormal_muscle_electrophysio | 1.41620440 |
| 46 | MP0002933_joint_inflammation | 1.41600079 |
| 47 | MP0005623_abnormal_meninges_morphology | 1.41517618 |
| 48 | MP0003879_abnormal_hair_cell | 1.34780853 |
| 49 | MP0001216_abnormal_epidermal_layer | 1.34148117 |
| 50 | MP0003436_decreased_susceptibility_to | 1.33120206 |
| 51 | MP0002405_respiratory_system_inflammati | 1.32552680 |
| 52 | MP0004510_myositis | 1.32047784 |
| 53 | MP0005166_decreased_susceptibility_to | 1.31276296 |
| 54 | MP0003693_abnormal_embryo_hatching | 1.29411447 |
| 55 | MP0009046_muscle_twitch | 1.27309607 |
| 56 | MP0003191_abnormal_cellular_cholesterol | 1.27273031 |
| 57 | MP0001348_abnormal_lacrimal_gland | 1.26771060 |
| 58 | MP0003075_altered_response_to | 1.26506907 |
| 59 | MP0001853_heart_inflammation | 1.24511835 |
| 60 | MP0003880_abnormal_central_pattern | 1.23807663 |
| 61 | MP0000465_gastrointestinal_hemorrhage | 1.23601161 |
| 62 | MP0002060_abnormal_skin_morphology | 1.21897313 |
| 63 | MP0009333_abnormal_splenocyte_physiolog | 1.21575464 |
| 64 | MP0005332_abnormal_amino_acid | 1.20749717 |
| 65 | MP0009785_altered_susceptibility_to | 1.18934207 |
| 66 | MP0008004_abnormal_stomach_pH | 1.18871723 |
| 67 | MP0003763_abnormal_thymus_physiology | 1.18423058 |
| 68 | MP0005083_abnormal_biliary_tract | 1.16558522 |
| 69 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.14581784 |
| 70 | MP0000013_abnormal_adipose_tissue | 1.14520580 |
| 71 | MP0008569_lethality_at_weaning | 1.14338520 |
| 72 | MP0005379_endocrine/exocrine_gland_phen | 1.12549620 |
| 73 | MP0001879_abnormal_lymphatic_vessel | 1.12010982 |
| 74 | MP0002254_reproductive_system_inflammat | 1.06033685 |
| 75 | MP0010771_integument_phenotype | 1.01342391 |
| 76 | MP0004885_abnormal_endolymph | 1.00544581 |
| 77 | MP0006036_abnormal_mitochondrial_physio | 1.00280508 |
| 78 | MP0003045_fibrosis | 0.98081707 |
| 79 | MP0004264_abnormal_extraembryonic_tissu | 0.96915534 |
| 80 | MP0003690_abnormal_glial_cell | 0.95946279 |
| 81 | MP0003656_abnormal_erythrocyte_physiolo | 0.95615026 |
| 82 | MP0008875_abnormal_xenobiotic_pharmacok | 0.93592847 |
| 83 | MP0003300_gastrointestinal_ulcer | 0.93068705 |
| 84 | MP0008057_abnormal_DNA_replication | 0.91305890 |
| 85 | MP0004147_increased_porphyrin_level | 0.90625283 |
| 86 | MP0010155_abnormal_intestine_physiology | 0.90172349 |
| 87 | MP0000003_abnormal_adipose_tissue | 0.88850915 |
| 88 | MP0005464_abnormal_platelet_physiology | 0.88546284 |
| 89 | MP0002136_abnormal_kidney_physiology | 0.86262112 |
| 90 | MP0009764_decreased_sensitivity_to | 0.85808051 |
| 91 | MP0002277_abnormal_respiratory_mucosa | 0.85737061 |
| 92 | MP0001986_abnormal_taste_sensitivity | 0.85093970 |
| 93 | MP0003453_abnormal_keratinocyte_physiol | 0.85043612 |
| 94 | MP0003186_abnormal_redox_activity | 0.84157589 |
| 95 | MP0008469_abnormal_protein_level | 0.83778887 |
| 96 | MP0003806_abnormal_nucleotide_metabolis | 0.83451066 |
| 97 | MP0001873_stomach_inflammation | 0.82458983 |
| 98 | MP0010352_gastrointestinal_tract_polyps | 0.82403307 |
| 99 | MP0005365_abnormal_bile_salt | 0.82142826 |
| 100 | MP0003866_abnormal_defecation | 0.80923297 |
| 101 | MP0002396_abnormal_hematopoietic_system | 0.80740656 |
| 102 | MP0002019_abnormal_tumor_incidence | 0.80218269 |
| 103 | MP0000343_altered_response_to | 0.79290379 |
| 104 | MP0003448_altered_tumor_morphology | 0.79270972 |
| 105 | MP0003252_abnormal_bile_duct | 0.79209492 |
| 106 | MP0004134_abnormal_chest_morphology | 0.78767994 |
| 107 | MP0005165_increased_susceptibility_to | 0.78211211 |
| 108 | MP0000604_amyloidosis | 0.78173271 |
| 109 | MP0000609_abnormal_liver_physiology | 0.77694734 |
| 110 | MP0001346_abnormal_lacrimal_gland | 0.77614336 |
| 111 | MP0009643_abnormal_urine_homeostasis | 0.77459229 |
| 112 | MP0001501_abnormal_sleep_pattern | 0.74378238 |
| 113 | MP0004142_abnormal_muscle_tone | 0.73151087 |
| 114 | MP0003329_amyloid_beta_deposits | 0.72386618 |
| 115 | MP0001191_abnormal_skin_condition | 0.71305488 |
| 116 | MP0008872_abnormal_physiological_respon | 0.71161563 |
| 117 | MP0001663_abnormal_digestive_system | 0.70986503 |
| 118 | MP0002272_abnormal_nervous_system | 0.70272350 |
| 119 | MP0008438_abnormal_cutaneous_collagen | 0.69076999 |
| 120 | MP0010329_abnormal_lipoprotein_level | 0.68383844 |
| 121 | MP0005388_respiratory_system_phenotype | 0.67954407 |
| 122 | MP0002133_abnormal_respiratory_system | 0.67954407 |
| 123 | MP0001545_abnormal_hematopoietic_system | 0.66936543 |
| 124 | MP0005397_hematopoietic_system_phenotyp | 0.66936543 |
| 125 | MP0003786_premature_aging | 0.66422965 |
| 126 | MP0005023_abnormal_wound_healing | 0.65770251 |
| 127 | MP0000703_abnormal_thymus_morphology | 0.65332075 |
| 128 | MP0001666_abnormal_nutrient_absorption | 0.65274053 |
| 129 | MP0002873_normal_phenotype | 0.64334671 |
| 130 | MP0000377_abnormal_hair_follicle | 0.64184327 |
| 131 | MP0002169_no_abnormal_phenotype | 0.64174272 |
| 132 | MP0002064_seizures | 0.64016892 |
| 133 | MP0003635_abnormal_synaptic_transmissio | 0.63734727 |
| 134 | MP0009278_abnormal_bone_marrow | 0.63547188 |
| 135 | MP0009931_abnormal_skin_appearance | 0.62680288 |
| 136 | MP0001533_abnormal_skeleton_physiology | 0.62343211 |
| 137 | MP0002909_abnormal_adrenal_gland | 0.62144028 |
| 138 | MP0001177_atelectasis | 0.61915208 |
| 139 | MP0000613_abnormal_salivary_gland | 0.61484811 |
| 140 | MP0003868_abnormal_feces_composition | 0.60596584 |
| 141 | MP0005164_abnormal_response_to | 0.59759978 |
| 142 | MP0000367_abnormal_coat/_hair | 0.56701280 |
| 143 | MP0001851_eye_inflammation | 0.56612070 |
| 144 | MP0008058_abnormal_DNA_repair | 0.56197419 |
| 145 | MP0002168_other_aberrant_phenotype | 0.54746441 |
| 146 | MP0004957_abnormal_blastocyst_morpholog | 0.53178902 |
| 147 | MP0000249_abnormal_blood_vessel | 0.49686255 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 8.29754944 |
| 2 | Abnormality of B cell number (HP:0010975) | 6.84032629 |
| 3 | B lymphocytopenia (HP:0010976) | 6.84032629 |
| 4 | Prostate neoplasm (HP:0100787) | 6.77522820 |
| 5 | Recurrent bronchitis (HP:0002837) | 6.25962701 |
| 6 | Recurrent sinusitis (HP:0011108) | 5.82305716 |
| 7 | Gastrointestinal stroma tumor (HP:0100723) | 5.49358792 |
| 8 | Cellulitis (HP:0100658) | 5.38559392 |
| 9 | Abnormality of nail color (HP:0100643) | 4.99801178 |
| 10 | Recurrent pneumonia (HP:0006532) | 4.84744653 |
| 11 | Papilloma (HP:0012740) | 4.79962472 |
| 12 | Verrucae (HP:0200043) | 4.79962472 |
| 13 | Abnormality of the prostate (HP:0008775) | 4.74664195 |
| 14 | Oral leukoplakia (HP:0002745) | 4.56405802 |
| 15 | Increased IgE level (HP:0003212) | 4.47203119 |
| 16 | IgM deficiency (HP:0002850) | 4.46837233 |
| 17 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 4.33469209 |
| 18 | Meningitis (HP:0001287) | 4.24928617 |
| 19 | Recurrent lower respiratory tract infections (HP:0002783) | 4.21585933 |
| 20 | Chronic sinusitis (HP:0011109) | 4.11859309 |
| 21 | Congenital ichthyosiform erythroderma (HP:0007431) | 4.05517860 |
| 22 | Abnormality of the pulmonary veins (HP:0011718) | 3.97895896 |
| 23 | Thyroiditis (HP:0100646) | 3.92900142 |
| 24 | IgG deficiency (HP:0004315) | 3.91400790 |
| 25 | Onycholysis (HP:0001806) | 3.70196091 |
| 26 | Abnormal umbilical cord blood vessels (HP:0011403) | 3.66597219 |
| 27 | Single umbilical artery (HP:0001195) | 3.66597219 |
| 28 | Abnormality of the fetal cardiovascular system (HP:0010948) | 3.66597219 |
| 29 | Recurrent viral infections (HP:0004429) | 3.65616953 |
| 30 | Colitis (HP:0002583) | 3.59288076 |
| 31 | Intestinal atresia (HP:0011100) | 3.46746443 |
| 32 | Bronchitis (HP:0012387) | 3.44429690 |
| 33 | Recurrent otitis media (HP:0000403) | 3.40742076 |
| 34 | Annular pancreas (HP:0001734) | 3.40625164 |
| 35 | Parakeratosis (HP:0001036) | 3.36848560 |
| 36 | Palmoplantar hyperkeratosis (HP:0000972) | 3.34729034 |
| 37 | IgA deficiency (HP:0002720) | 3.28694457 |
| 38 | Gangrene (HP:0100758) | 3.28431072 |
| 39 | Osteomyelitis (HP:0002754) | 3.25415501 |
| 40 | Alopecia of scalp (HP:0002293) | 3.24420888 |
| 41 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.23061973 |
| 42 | Erythroderma (HP:0001019) | 3.20113853 |
| 43 | Paralysis (HP:0003470) | 3.15086083 |
| 44 | Sepsis (HP:0100806) | 3.13157590 |
| 45 | Palmar hyperkeratosis (HP:0010765) | 3.09037664 |
| 46 | Panhypogammaglobulinemia (HP:0003139) | 3.05859505 |
| 47 | Erythema (HP:0010783) | 3.05649510 |
| 48 | Chronic otitis media (HP:0000389) | 3.01772278 |
| 49 | Urticaria (HP:0001025) | 3.00116284 |
| 50 | Abnormality of T cell number (HP:0011839) | 2.99234462 |
| 51 | Autoimmune thrombocytopenia (HP:0001973) | 2.98583732 |
| 52 | Abnormality of macrophages (HP:0004311) | 2.95286662 |
| 53 | Neonatal death (HP:0003811) | 2.91025443 |
| 54 | Skin rash (HP:0000988) | 2.89366000 |
| 55 | Premature loss of primary teeth (HP:0006323) | 2.89171258 |
| 56 | Abnormality of T cell physiology (HP:0011840) | 2.86629262 |
| 57 | Ectropion (HP:0000656) | 2.82347462 |
| 58 | Plantar hyperkeratosis (HP:0007556) | 2.81553440 |
| 59 | Vasculitis (HP:0002633) | 2.80469875 |
| 60 | Emphysema (HP:0002097) | 2.78916697 |
| 61 | Hypoplasia of the thymus (HP:0000778) | 2.78348025 |
| 62 | Corneal erosion (HP:0200020) | 2.77326578 |
| 63 | Xerostomia (HP:0000217) | 2.67914461 |
| 64 | Hydroureter (HP:0000072) | 2.67641373 |
| 65 | Interstitial pulmonary disease (HP:0006530) | 2.65672512 |
| 66 | Abnormality of T cells (HP:0002843) | 2.60127461 |
| 67 | Amniotic constriction ring (HP:0009775) | 2.59748667 |
| 68 | Abnormality of placental membranes (HP:0011409) | 2.59748667 |
| 69 | Combined immunodeficiency (HP:0005387) | 2.59182892 |
| 70 | Small epiphyses (HP:0010585) | 2.58253227 |
| 71 | Leukocytosis (HP:0001974) | 2.57166763 |
| 72 | Severe combined immunodeficiency (HP:0004430) | 2.53438648 |
| 73 | Abnormality of male internal genitalia (HP:0000022) | 2.52986046 |
| 74 | Mitral stenosis (HP:0001718) | 2.50184468 |
| 75 | Restrictive lung disease (HP:0002091) | 2.49711439 |
| 76 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.49491330 |
| 77 | Myositis (HP:0100614) | 2.49456885 |
| 78 | T lymphocytopenia (HP:0005403) | 2.47894728 |
| 79 | Recurrent bacterial skin infections (HP:0005406) | 2.47529502 |
| 80 | Pustule (HP:0200039) | 2.47209272 |
| 81 | Recurrent abscess formation (HP:0002722) | 2.45682122 |
| 82 | Acute encephalopathy (HP:0006846) | 2.43763798 |
| 83 | Lymphopenia (HP:0001888) | 2.41809468 |
| 84 | Mucosal telangiectasiae (HP:0100579) | 2.39747493 |
| 85 | Acute necrotizing encephalopathy (HP:0006965) | 2.38753580 |
| 86 | Colon cancer (HP:0003003) | 2.37534379 |
| 87 | Inflammation of the large intestine (HP:0002037) | 2.35175855 |
| 88 | Abnormal lung lobation (HP:0002101) | 2.32364170 |
| 89 | Progressive macrocephaly (HP:0004481) | 2.31067362 |
| 90 | Amaurosis fugax (HP:0100576) | 2.28100685 |
| 91 | Abnormality of the umbilical cord (HP:0010881) | 2.27415165 |
| 92 | Pruritus (HP:0000989) | 2.27135018 |
| 93 | Vacuolated lymphocytes (HP:0001922) | 2.25655181 |
| 94 | Gastrointestinal inflammation (HP:0004386) | 2.22952786 |
| 95 | Acrocyanosis (HP:0001063) | 2.22679694 |
| 96 | Hypertensive crisis (HP:0100735) | 2.22197920 |
| 97 | Thick nail (HP:0001805) | 2.21807474 |
| 98 | Lymphoma (HP:0002665) | 2.20735674 |
| 99 | Recurrent fungal infections (HP:0002841) | 2.18139988 |
| 100 | Ridged nail (HP:0001807) | 2.17698571 |
| 101 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.17271489 |
| 102 | Pulmonary infiltrates (HP:0002113) | 2.13978170 |
| 103 | Sparse eyelashes (HP:0000653) | 2.10830742 |
| 104 | Deep venous thrombosis (HP:0002625) | 2.10657088 |
| 105 | Arthralgia (HP:0002829) | 2.08858609 |
| 106 | Abnormality of the intrinsic pathway (HP:0010989) | 2.08683798 |
| 107 | Chest pain (HP:0100749) | 2.08463923 |
| 108 | Eosinophilia (HP:0001880) | 2.08069530 |
| 109 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.06223030 |
| 110 | Hypotrichosis (HP:0001006) | 2.03440540 |
| 111 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.01696392 |
| 112 | Increased IgM level (HP:0003496) | 2.01686316 |
| 113 | Clubbing of toes (HP:0100760) | 2.00881656 |
| 114 | Abnormality of the axillary hair (HP:0100134) | 2.00210540 |
| 115 | Abnormality of secondary sexual hair (HP:0009888) | 2.00210540 |
| 116 | Dehydration (HP:0001944) | 1.99783173 |
| 117 | Abnormal gallbladder morphology (HP:0012437) | 1.98774149 |
| 118 | Nonimmune hydrops fetalis (HP:0001790) | 1.98603400 |
| 119 | Hypoproteinemia (HP:0003075) | 1.98511488 |
| 120 | Meckel diverticulum (HP:0002245) | 1.96985354 |
| 121 | Abnormal foot bone ossification (HP:0010675) | 1.96510508 |
| 122 | Neoplasm of the lung (HP:0100526) | 1.95732060 |
| 123 | Hypoplastic left heart (HP:0004383) | 1.95555364 |
| 124 | Abnormality of the labia minora (HP:0012880) | 1.95413019 |
| 125 | Gastrointestinal infarctions (HP:0005244) | 1.95222870 |
| 126 | Cholelithiasis (HP:0001081) | 1.94115235 |
| 127 | Recurrent skin infections (HP:0001581) | 1.93930888 |
| 128 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.93476119 |
| 129 | Keratoconjunctivitis (HP:0001096) | 1.92117014 |
| 130 | Skin ulcer (HP:0200042) | 1.91226453 |
| 131 | Limb hypertonia (HP:0002509) | 1.90579370 |
| 132 | Keratoconjunctivitis sicca (HP:0001097) | 1.90133848 |
| 133 | Autoimmune hemolytic anemia (HP:0001890) | 1.77543012 |
| 134 | Leukodystrophy (HP:0002415) | 1.77397691 |
| 135 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.77363511 |
| 136 | Neutropenia (HP:0001875) | 1.75535613 |
| 137 | Conjunctival hamartoma (HP:0100780) | 1.74996384 |
| 138 | Hepatocellular necrosis (HP:0001404) | 1.74963037 |
| 139 | Thrombocytosis (HP:0001894) | 1.72689096 |
| 140 | Hyperventilation (HP:0002883) | 1.69613150 |
| 141 | Camptodactyly of toe (HP:0001836) | 1.68550374 |
| 142 | Cerebral edema (HP:0002181) | 1.68296002 |
| 143 | Papilledema (HP:0001085) | 1.67890370 |
| 144 | Eczematoid dermatitis (HP:0000976) | 1.67197413 |
| 145 | Hypergammaglobulinemia (HP:0010702) | 1.66941219 |
| 146 | Metaphyseal cupping (HP:0003021) | 1.66807471 |
| 147 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.65965975 |
| 148 | Abnormal tarsal ossification (HP:0008369) | 1.65532512 |
| 149 | Exercise-induced myalgia (HP:0003738) | 1.64118569 |
| 150 | Intrahepatic cholestasis (HP:0001406) | 1.63803188 |
| 151 | Long clavicles (HP:0000890) | 1.62348364 |
| 152 | Abnormality of eosinophils (HP:0001879) | 1.61632492 |
| 153 | Abnormality of the lumbar spine (HP:0100712) | 1.60722298 |
| 154 | Irregular vertebral endplates (HP:0003301) | 1.60484670 |
| 155 | Leukopenia (HP:0001882) | 1.59016424 |
| 156 | Beaking of vertebral bodies (HP:0004568) | 1.58867535 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 5.32920412 |
| 2 | TAF1 | 4.34906039 |
| 3 | MAP4K1 | 4.30554146 |
| 4 | SMG1 | 4.07605382 |
| 5 | ERN1 | 3.31692954 |
| 6 | BUB1 | 3.10026559 |
| 7 | RIPK4 | 2.80305607 |
| 8 | SYK | 2.79785020 |
| 9 | EIF2AK1 | 2.60255910 |
| 10 | PRKCH | 2.53172313 |
| 11 | KIT | 2.22942682 |
| 12 | LYN | 2.20044075 |
| 13 | BMPR2 | 2.19493223 |
| 14 | BCKDK | 2.18577775 |
| 15 | IRAK4 | 2.18305264 |
| 16 | STK24 | 2.13939003 |
| 17 | MAP3K13 | 2.11983067 |
| 18 | CSF1R | 2.08607778 |
| 19 | CCNB1 | 2.07121422 |
| 20 | ZAK | 2.03875510 |
| 21 | TXK | 2.01517868 |
| 22 | GRK6 | 2.01158462 |
| 23 | MAP3K4 | 1.96424600 |
| 24 | MAP3K14 | 1.92572845 |
| 25 | TBK1 | 1.86921095 |
| 26 | FES | 1.83129431 |
| 27 | MST4 | 1.78544704 |
| 28 | BTK | 1.68215462 |
| 29 | ITK | 1.64755819 |
| 30 | PRKCQ | 1.62369806 |
| 31 | BLK | 1.60490599 |
| 32 | EIF2AK3 | 1.57090268 |
| 33 | BCR | 1.56821029 |
| 34 | TAOK3 | 1.54844844 |
| 35 | CLK1 | 1.53168292 |
| 36 | GRK1 | 1.52766042 |
| 37 | TYK2 | 1.50729100 |
| 38 | SIK2 | 1.50573109 |
| 39 | MAPKAPK5 | 1.48483220 |
| 40 | STK38L | 1.45942491 |
| 41 | FRK | 1.41983467 |
| 42 | NEK1 | 1.41714537 |
| 43 | TLK1 | 1.38802348 |
| 44 | FGFR2 | 1.36985855 |
| 45 | NME1 | 1.29740766 |
| 46 | PIK3CG | 1.23852965 |
| 47 | PRKCI | 1.20847686 |
| 48 | NEK2 | 1.14356050 |
| 49 | FGFR3 | 1.13363605 |
| 50 | IRAK3 | 1.13172462 |
| 51 | PLK3 | 1.12139758 |
| 52 | HCK | 1.04945770 |
| 53 | PIK3CA | 1.01772662 |
| 54 | CSNK1G3 | 1.01586962 |
| 55 | BMX | 1.00516742 |
| 56 | STK10 | 0.99750898 |
| 57 | MAP3K9 | 0.99483507 |
| 58 | PLK2 | 0.99012788 |
| 59 | IKBKB | 0.98837528 |
| 60 | TTN | 0.98761851 |
| 61 | SIK1 | 0.98427142 |
| 62 | BRSK1 | 0.96911670 |
| 63 | UHMK1 | 0.96118494 |
| 64 | MELK | 0.95656909 |
| 65 | NEK9 | 0.92489752 |
| 66 | EPHA3 | 0.91694783 |
| 67 | LCK | 0.90737979 |
| 68 | MATK | 0.90431536 |
| 69 | NME2 | 0.88619409 |
| 70 | PRKCD | 0.88527348 |
| 71 | OXSR1 | 0.88333555 |
| 72 | CSNK1A1L | 0.86962633 |
| 73 | EPHA4 | 0.84313536 |
| 74 | IRAK1 | 0.84195795 |
| 75 | FYN | 0.84065067 |
| 76 | JAK1 | 0.83760002 |
| 77 | NTRK3 | 0.79108580 |
| 78 | PKN1 | 0.78448921 |
| 79 | ARAF | 0.77475583 |
| 80 | CSNK1G2 | 0.76451977 |
| 81 | HIPK2 | 0.72995296 |
| 82 | PIM1 | 0.72271068 |
| 83 | MAPK12 | 0.70282335 |
| 84 | DAPK1 | 0.70065961 |
| 85 | DAPK3 | 0.68934576 |
| 86 | ZAP70 | 0.68624214 |
| 87 | TEC | 0.67647202 |
| 88 | PRKD1 | 0.67406558 |
| 89 | KSR2 | 0.65108789 |
| 90 | ADRBK2 | 0.64491895 |
| 91 | MAP3K5 | 0.64058630 |
| 92 | BMPR1B | 0.62947624 |
| 93 | CSK | 0.60222699 |
| 94 | CSNK1G1 | 0.59497285 |
| 95 | FGFR4 | 0.59316950 |
| 96 | TTK | 0.58680855 |
| 97 | LRRK2 | 0.58244455 |
| 98 | MAP3K3 | 0.57408523 |
| 99 | TGFBR2 | 0.56767079 |
| 100 | STK4 | 0.56520046 |
| 101 | MST1R | 0.56485900 |
| 102 | CAMKK1 | 0.54270559 |
| 103 | CDK9 | 0.53042875 |
| 104 | PRKCZ | 0.52032863 |
| 105 | CDK15 | 0.50363481 |
| 106 | RPS6KA6 | 0.49709191 |
| 107 | EIF2AK2 | 0.49603863 |
| 108 | CDC42BPA | 0.47779126 |
| 109 | STK3 | 0.47598706 |
| 110 | TGFBR1 | 0.46983238 |
| 111 | NUAK1 | 0.46583454 |
| 112 | ALK | 0.46172306 |
| 113 | DDR2 | 0.45818955 |
| 114 | LMTK2 | 0.45625988 |
| 115 | RPS6KC1 | 0.44546150 |
| 116 | RPS6KL1 | 0.44546150 |
| 117 | STK39 | 0.44200517 |
| 118 | CDK18 | 0.44188407 |
| 119 | STK16 | 0.43366658 |
| 120 | INSR | 0.42647014 |
| 121 | CDK14 | 0.40793424 |
| 122 | PRPF4B | 0.39781439 |
| 123 | MAPKAPK2 | 0.39290903 |
| 124 | PRKCG | 0.39134005 |
| 125 | MYLK | 0.38729204 |
| 126 | GRK5 | 0.38084531 |
| 127 | MAPK4 | 0.37868403 |
| 128 | MAP3K10 | 0.37599891 |
| 129 | CDK5 | 0.36982220 |
| 130 | DYRK1B | 0.36585928 |
| 131 | IKBKE | 0.35187701 |
| 132 | MAP3K8 | 0.35007394 |
| 133 | VRK1 | 0.34563564 |
| 134 | CAMK2A | 0.33875430 |
| 135 | CHUK | 0.31891658 |
| 136 | AURKB | 0.30683730 |
| 137 | CDK11A | 0.30365042 |
| 138 | JAK2 | 0.30235683 |
| 139 | JAK3 | 0.29604613 |
| 140 | MAP3K12 | 0.28805059 |
| 141 | FGR | 0.28143976 |
| 142 | MAPK7 | 0.26380202 |
| 143 | FER | 0.25450867 |
| 144 | MKNK2 | 0.25379248 |
| 145 | MAP2K6 | 0.23659963 |
| 146 | IGF1R | 0.22561328 |
| 147 | WEE1 | 0.22533019 |
| 148 | EPHB1 | 0.19289371 |
| 149 | MAP2K3 | 0.18918843 |
| 150 | ATR | 0.17465904 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 8.50553576 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.37284875 |
| 3 | Protein export_Homo sapiens_hsa03060 | 4.48152735 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.21141784 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.09624110 |
| 6 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 3.02541272 |
| 7 | Proteasome_Homo sapiens_hsa03050 | 2.16753241 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.16630798 |
| 9 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.95050190 |
| 10 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.84899788 |
| 11 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.83700413 |
| 12 | DNA replication_Homo sapiens_hsa03030 | 1.73322960 |
| 13 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.67837325 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 1.48476664 |
| 15 | Asthma_Homo sapiens_hsa05310 | 1.45333808 |
| 16 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.45221485 |
| 17 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.34446044 |
| 18 | Influenza A_Homo sapiens_hsa05164 | 1.32698206 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.32324054 |
| 20 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.27900812 |
| 21 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.26849789 |
| 22 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.24616842 |
| 23 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.23242957 |
| 24 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.22791699 |
| 25 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.20488109 |
| 26 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.18508387 |
| 27 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.17511445 |
| 28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.12752509 |
| 29 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.12221999 |
| 30 | Leishmaniasis_Homo sapiens_hsa05140 | 1.11656713 |
| 31 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.10477078 |
| 32 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.08016456 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.07313723 |
| 34 | Homologous recombination_Homo sapiens_hsa03440 | 1.07298147 |
| 35 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.06271591 |
| 36 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.01939083 |
| 37 | Alzheimers disease_Homo sapiens_hsa05010 | 1.01934114 |
| 38 | Mismatch repair_Homo sapiens_hsa03430 | 1.01370030 |
| 39 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.00292310 |
| 40 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.99294163 |
| 41 | Other glycan degradation_Homo sapiens_hsa00511 | 0.97601588 |
| 42 | Base excision repair_Homo sapiens_hsa03410 | 0.97361272 |
| 43 | Malaria_Homo sapiens_hsa05144 | 0.95840082 |
| 44 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.95663547 |
| 45 | Measles_Homo sapiens_hsa05162 | 0.95092723 |
| 46 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.87678918 |
| 47 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.87310308 |
| 48 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.85262666 |
| 49 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.84328966 |
| 50 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.84206597 |
| 51 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.83428696 |
| 52 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82814072 |
| 53 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.77315128 |
| 54 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.77177892 |
| 55 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.72327471 |
| 56 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.71546798 |
| 57 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.71392712 |
| 58 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.71230549 |
| 59 | Pertussis_Homo sapiens_hsa05133 | 0.71123338 |
| 60 | Viral myocarditis_Homo sapiens_hsa05416 | 0.68492373 |
| 61 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.67862151 |
| 62 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.67008284 |
| 63 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.66889469 |
| 64 | Tuberculosis_Homo sapiens_hsa05152 | 0.66310636 |
| 65 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65971107 |
| 66 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.65435539 |
| 67 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.65427931 |
| 68 | Histidine metabolism_Homo sapiens_hsa00340 | 0.65146682 |
| 69 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.63979287 |
| 70 | Parkinsons disease_Homo sapiens_hsa05012 | 0.62574511 |
| 71 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.60927589 |
| 72 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.60765362 |
| 73 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.60717765 |
| 74 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.59139629 |
| 75 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.57927761 |
| 76 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.57212590 |
| 77 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.56748370 |
| 78 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.56399470 |
| 79 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.55586912 |
| 80 | Apoptosis_Homo sapiens_hsa04210 | 0.54623549 |
| 81 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.54542183 |
| 82 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.54219240 |
| 83 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.53330276 |
| 84 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.52725051 |
| 85 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.52194870 |
| 86 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51880548 |
| 87 | Peroxisome_Homo sapiens_hsa04146 | 0.51713065 |
| 88 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.50644315 |
| 89 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50425678 |
| 90 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.49465675 |
| 91 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.49341446 |
| 92 | Long-term potentiation_Homo sapiens_hsa04720 | 0.48124570 |
| 93 | Ribosome_Homo sapiens_hsa03010 | 0.48022767 |
| 94 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.45391110 |
| 95 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.44698692 |
| 96 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.41828436 |
| 97 | GABAergic synapse_Homo sapiens_hsa04727 | 0.40866553 |
| 98 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.40820332 |
| 99 | Circadian entrainment_Homo sapiens_hsa04713 | 0.40760024 |
| 100 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.40237836 |
| 101 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.39636352 |
| 102 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.39481847 |
| 103 | RNA degradation_Homo sapiens_hsa03018 | 0.38509959 |
| 104 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.35694133 |
| 105 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.34725388 |
| 106 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.34342485 |
| 107 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.33790014 |
| 108 | Hepatitis B_Homo sapiens_hsa05161 | 0.33081551 |
| 109 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.32506157 |
| 110 | Platelet activation_Homo sapiens_hsa04611 | 0.32270258 |
| 111 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.32076202 |
| 112 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.32064686 |
| 113 | Renin secretion_Homo sapiens_hsa04924 | 0.31877048 |
| 114 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.31775773 |
| 115 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.31144020 |
| 116 | Phagosome_Homo sapiens_hsa04145 | 0.29432310 |
| 117 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.28963081 |
| 118 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.28413366 |
| 119 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.28093926 |
| 120 | Carbon metabolism_Homo sapiens_hsa01200 | 0.27484644 |
| 121 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.27085336 |
| 122 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.27057329 |
| 123 | Bile secretion_Homo sapiens_hsa04976 | 0.26596510 |
| 124 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.26522401 |
| 125 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.25651685 |
| 126 | Legionellosis_Homo sapiens_hsa05134 | 0.24969747 |
| 127 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.24395518 |
| 128 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.23615939 |
| 129 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.22880497 |
| 130 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.21703132 |
| 131 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.21572939 |
| 132 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.21526705 |
| 133 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.20807002 |
| 134 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.19612831 |
| 135 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.14331588 |
| 136 | Hepatitis C_Homo sapiens_hsa05160 | 0.14195521 |
| 137 | Amoebiasis_Homo sapiens_hsa05146 | 0.12617802 |
| 138 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.11326705 |
| 139 | Purine metabolism_Homo sapiens_hsa00230 | 0.11040704 |
| 140 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.09166165 |
| 141 | Alcoholism_Homo sapiens_hsa05034 | 0.08105807 |

